LISATA THERAPEUTICS, INC. — Director's Dealing 2014

Jan 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-01-02

Reporting Person: Potter Stephen W (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-02	Stock Option (right to purchase)	$7.77	A	35000	Acquired	2024-01-01	Common Stock, par value $0.001 per share (35000)	Direct

Footnotes

F1: On January 2, 2014 (the "Grant Date"), the Reporting Person was granted an option (the "Option") to purchase shares (the "Option Shares") of the Issuer's common stock, $.001 par value, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan. The Option vests as follows: (i) as to 25% of the Option Shares on the date of grant, (ii) as to 25% of the Option Shares on January 2, 2015, (iii) as to 25% of the Option Shares upon the achievement of a certain specified business milestone, and (iv) as to the remaining 25% of the Option Shares upon the achievement of an additional certain specified business milestone.